New Research Funding From Solve M.E. Advances Innovative ME/CFS and Long Covid Studies Toward Treatments

Two Solve Catalyst Award-winning projects will expand whole-genome discovery and test a promising low-cost therapy targeting inflammation and energy dysfunction—key steps toward biomarkers and clinical trials. LOS ANGELES, May 12, 2026 /PRNewswire/ -- In recognition of World ME Awareness...